These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 91451)

  • 41. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
    Singh BN; Feld G; Nademanee K
    Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined effects of glucose and hypoxia on cardiac automaticity and conduction.
    Senges J; Brachmann J; Pelzer D; Krämer B; Kübler W
    J Mol Cell Cardiol; 1980 Mar; 12(3):311-23. PubMed ID: 7373657
    [No Abstract]   [Full Text] [Related]  

  • 44. Removal of toxic levels of N-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration.
    Domoto DT; Brown WW; Bruggensmith P
    Ann Intern Med; 1987 Apr; 106(4):550-2. PubMed ID: 2435200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative studies of the hemodynamic effects of procainamide and N-acetylprocainamide in rabbits].
    Matusewicz W
    Kardiol Pol; 1984; 27(5):393-400. PubMed ID: 6208404
    [No Abstract]   [Full Text] [Related]  

  • 46. The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias.
    Kluger J; Drayer D; Reidenberg M; Ellis G; Lloyd V; Tyberg T; Hayes J
    Am J Cardiol; 1980 Jun; 45(6):1250-7. PubMed ID: 6155064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemoperfusion for treatment of N-acetylprocainamide intoxication.
    Braden GL; Fitzgibbons JP; Germain MJ; Ledewitz HM
    Ann Intern Med; 1986 Jul; 105(1):64-5. PubMed ID: 2424355
    [No Abstract]   [Full Text] [Related]  

  • 48. Dromotropic effects of adenosine and adenosine antagonists in the treatment of cardiac arrhythmias involving the atrioventricular node.
    Berne RM; DiMarco JP; Belardinelli L
    Circulation; 1984 Jun; 69(6):1195-7. PubMed ID: 6713621
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
    Lahita R; Kluger J; Drayer DE; Koffler D; Reidenberg MM
    N Engl J Med; 1979 Dec; 301(25):1382-5. PubMed ID: 91972
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of effects of glucagon and isoprenaline on atrio-ventricular conduction and sino-atrial rate in the dog heart.
    Iijima T; Motomura S; Taira N; Hashimoto K
    Clin Exp Pharmacol Physiol; 1974; 1(3):241-8. PubMed ID: 4458996
    [No Abstract]   [Full Text] [Related]  

  • 51. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Electrophysiologic characterization of propafenone in man].
    Masini G; Dianda R; Masini M
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
    Marchlinski FE; Buxton AE; Vassallo JA; Waxman HL; Cassidy DM; Doherty JU; Josephson ME
    J Am Coll Cardiol; 1984 Dec; 4(6):1247-54. PubMed ID: 6209319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative electrophysiologic effects of bepridil, verapamil and diltiazem in conscious and anesthetized dogs.
    Kantelip JP; Alatienne M; Talmant JM; Ghyselinck N; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):5-18. PubMed ID: 3493741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thin-layer chromatographic determination of procainamide and N-acetylprocainamide in human serum and urine at single-dose levels.
    Kark B; Sistovaris N; Keller A
    J Chromatogr; 1983 Oct; 277():261-72. PubMed ID: 6196373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.
    Mangiardi LM; Hariman RJ; McAllister RG; Bhargava V; Surawicz B; Shabetai R
    Circulation; 1978 Feb; 57(2):366-72. PubMed ID: 618628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The electrophysiologic effects of procainamide in the immature heart.
    Shih JY; Gillette PC; Kugler JD; Garson A; Fukushige J; Zinner A; Driscoll DJ
    Pediatr Pharmacol (New York); 1982; 2(1):65-73. PubMed ID: 7110758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease.
    Kates RE; Jaillon P; Rubenson DS; Winkle RA
    Clin Pharmacol Ther; 1980 Jul; 28(1):52-7. PubMed ID: 6156049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR; Dhruv RA
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.